Takeda turns to OTCs to bolster Japanese top line
This article was originally published in Scrip
Executive Summary
Takeda has acquired exclusive distribution rights in Japan to seven over-the-counter (OTC) products currently sold by Johnson & Johnson KK Consumer Company, in a move apparently aimed at propping up Takeda's sales top line amid weakness in its domestic prescription business.